版本:
中国

BRIEF-Permira Funds to acquire lSNE

March 27 Clairvest Group Inc:

* Permira Funds to acquire lSNE, a leading CDMO for the pharmaceutical and medical device markets, in partnership with management

* Permira - lSNE founder, CEO Matt Halvorsen will maintain a significant equity stake in company and will continue to lead company in his current role

* Permira - Claes Glassell, former CEO of CMC Biologics will join as chairman of board of lSNE

* Permira - company backed by Permira Funds has signed a definitive agreement to acquire lyophilization services of New England, Inc Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐